Alterations in tubular epithelial cells in diabetic nephropathy

被引:25
作者
Habib, Samy L. [1 ,2 ]
机构
[1] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Dept, San Antonio, TX USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Cellular & Struct Biol Dept, San Antonio, TX 78229 USA
关键词
Cell matrix protein; Diabetes; Fibrosis; Tubular injury; MAMMALIAN TARGET; RAPAMYCIN; PATHWAY; TSC2; FIBRONECTIN; GROWTH; MTOR;
D O I
10.5301/jn.5000287
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal hypertrophy, matrix protein accumulation and tubulointerstitial fibrosis are major pathological features of diabetic nephropathy (DN) that eventuate in renal failure. Hyperglycemia and high concentration of glucose increase matrix protein expression, but the pathogenic Mechanisms are not fully understood. We have previously reported that inactivation of tuberin resulting in activation of the mammalian target of rapamycin (mTOR) pathway and increased matrix protein accumulation in cultured proximal tubular cells exposed to high glucose and in kidney cortex of rats with type 1 diabetes. In this report, we show that kidney sections of diabetic patients express higher levels of phospho-tuberin (inactive form of tuberin), and that is associated with an increase in mTOR activation as measured by phosphorylation level of p70S6K. Inactivation of tuberin and activation Of mTOR lead to accumulated cell matrix proteins (fibronectin and collagen IV) mainly in tubular epithelial cells of the kidneys of diabetic patients. In addition, significant staining of vimentin as a marker of cells undergoing an epithelial-to-mesenchymal transition (EMT) was detected in kidney sections of diabetic patients. On the other hand, very weak or nondetectable staining of cell matrix proteins, p-tuberin and P-p70S6K at Well as vimentin was found in normal kidney sections of healthy subjects. The morphological changes in kidney sections of diabetic patients showed tubular thickening, glomerular and tubular hypertrophy, compared to normal structure of tubuli and glomeruli in kidney from healthy control subjects. These data suggest that alterations in tubular cells' structure, including tubular thickening and hypertrophy, are major mediators of the fibrotic process in DN.
引用
收藏
页码:865 / 869
页数:5
相关论文
共 17 条
[1]   Proximal tubular basement membrane width in insulin-dependent diabetes mellitus [J].
Brito, PL ;
Fioretto, P ;
Drummond, K ;
Kim, YK ;
Steffes, MW ;
Basgen, JM ;
Sisson-Ross, S ;
Mauer, M .
KIDNEY INTERNATIONAL, 1998, 53 (03) :754-761
[2]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[3]   Tuberin Inhibits Production of the Matrix Protein Fibronectin in Diabetes [J].
Habib, Samy L. ;
Yadav, Mukesh ;
Tizani, Shaza ;
Bhandari, Basant ;
Valente, Anthony J. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10) :1652-1662
[4]   EARLY INCREASED RENAL PROCOLLAGEN ALPHA-1(IV) MESSENGER-RNA LEVELS IN STREPTOZOTOCIN INDUCED DIABETES [J].
IHM, CG ;
LEE, GSL ;
NAST, CC ;
ARTISHEVSKY, A ;
GUILLERMO, R ;
LEVIN, PS ;
GLASSOCK, RJ ;
ADLER, SG .
KIDNEY INTERNATIONAL, 1992, 41 (04) :768-777
[5]   TSC2 mediates cellular energy response to control cell growth and survival [J].
Inoki, K ;
Zhu, TQ ;
Guan, KL .
CELL, 2003, 115 (05) :577-590
[6]   Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling [J].
Inoki, K ;
Li, Y ;
Xu, T ;
Guan, KL .
GENES & DEVELOPMENT, 2003, 17 (15) :1829-1834
[7]  
Kenerson HL, 2002, CANCER RES, V62, P5645
[8]   The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease [J].
Lieberthal, Wilfred ;
Levine, Jerrold S. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (12) :2493-2502
[9]   Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention [J].
Liu, YH .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01) :1-12
[10]   Intermittent supplementation with rapamycin as a dietary restriction mimetic [J].
Longo, Valter D. ;
Fontana, Luigi .
AGING-US, 2011, 3 (11) :1039-1040